INS and metabolic dysfunction-associated steatotic liver disease: In MASLD, higher HDL levels are also linked to improved insulin sensitivity and reduced hepatic steatosis (Mandraffino et al. 2022; El Amrousy et al. 2022), implying that this moderate elevation could have both metabolic and hepatic clinical relevance, even if the causal role of HDL per se remains debated.